Genetic clues could help young women beat uterine cancer and still have babies
NCT ID NCT06799624
Summary
This study aims to understand how different genetic types of early-stage uterine cancer respond to treatments that preserve fertility. Researchers will follow 100 young women (ages 18-45) who choose hormone therapy instead of a hysterectomy. The goal is to see if genetic testing of the tumor can better predict treatment success and future pregnancy chances.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Milan, Michigan, 20133, Italy
Conditions
Explore the condition pages connected to this study.